SEER Program

"SEER Program" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

Descriptor ID	D018426
MeSH Number(s)	E05.318.308.970.725 N04.452.859.819.725 N05.715.360.300.715.700.725 N06.850.520.308.970.725
Concept/Terms	SEER Program SEER Program Program, SEER SEER Program (National Cancer Institute (U.S.)) Surveillance, Epidemiology, and End Results Program

Below are MeSH descriptors whose meaning is more general than "SEER Program".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Data Collection [E05.318.308]
Registries [E05.318.308.970]
SEER Program [E05.318.308.970.725]
Health Care [N]
Health Services Administration [N04]
Organization and Administration [N04.452]
Records as Topic [N04.452.859]
Registries [N04.452.859.819]
SEER Program [N04.452.859.819.725]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Data Collection [N05.715.360.300]
Records as Topic [N05.715.360.300.715]
Registries [N05.715.360.300.715.700]
SEER Program [N05.715.360.300.715.700.725]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Data Collection [N06.850.520.308]
Registries [N06.850.520.308.970]
SEER Program [N06.850.520.308.970.725]

Below are MeSH descriptors whose meaning is related to "SEER Program".

Below are MeSH descriptors whose meaning is more specific than "SEER Program".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "SEER Program" by people in this website by year, and whether "SEER Program" was a major or minor topic of these publications.

Bar chart showing 146 publications over 25 distinct years, with a maximum of 13 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	4	5
2003	0	3	3
2004	0	2	2
2005	1	8	9
2006	0	10	10
2007	1	6	7
2008	2	9	11
2009	0	2	2
2010	1	2	3
2011	1	4	5
2012	1	4	5
2013	0	7	7
2014	1	10	11
2015	0	10	10
2016	1	6	7
2017	2	3	5
2018	1	2	3
2019	0	6	6
2020	1	0	1
2021	1	6	7
2022	0	1	1
2023	0	3	3
2024	6	7	13
2025	1	6	7
2026	0	3	3

Below are the most recent publications written about "SEER Program" by people in Profiles.

Akinyemi O, Fasokun M, Eze A, Ugochukwu N, Arshad S, Belie O, Hughes K, Cornwell Iii E, Levy G. Association of medicaid expansion with lung cancer-specific and overall mortality: A difference-in-differences analysis. PLoS One. 2026; 21(4):e0332292.

View in: PubMed
Gbogbo D, Tawk R, Ali AA, Reyes-Ortiz CA, Kiros GE. Impact of Pre-Diagnosed Depressive Symptoms on Treatment Choice, Delay in Initiating Treatment, and Mortality Among Women Aged =65 Years with Breast Cancer. Int J Environ Res Public Health. 2026 Mar 12; 23(3).

View in: PubMed
Sherr HR, Soliman AS, Bertrand KA, Hirko KA. Persistent poverty and breast cancer incidence by tumor subtype: intersections of rural/urban residence and race within USA Surveillance Epidemiology and End Results Registries, 2017 to 2021. Cancer Causes Control. 2026 Jan 17; 37(2):26.

View in: PubMed
Yazzie D, Pete D, Briscoe C, Jim MA, Meisner A, Wiggins C, Doyle D, Yee G, Goldtooth C, Sanderson PR, Keene CN, Smith M, Sehn H, Damon S, Kettering CL, Emerson M, Curley C, Bea J, Yazzie S, Joe N, Doherty J, Dirk de Heer H. Cancer incidence, stage at diagnosis, and trends across the Navajo Nation, 2014-2018. Cancer. 2025 Dec 15; 131(24):e70202.

View in: PubMed
Su J, Kieu J, Wong A, Hernandez BY, Loo LW, Marumoto A. Breast Cancer Surgery Practice Patterns in Hawai'i Compared to the Rest of the U.S. Hawaii J Health Soc Welf. 2025 11; 84(11):243-250.

View in: PubMed
Suk R, Lin YY, Dilley S, Chandler R, Xiao R, Shao H, Wells J. Survival by Treatment Recommendation and Receipt Among Older Patients With Early-Stage Cervical Cancer. JAMA Netw Open. 2025 Sep 02; 8(9):e2532206.

View in: PubMed
Sherr HR, Soliman AS, Bertrand KA, Hirko KA. Persistent poverty and late-stage breast cancer diagnosis in the USA: impacts of rural residence, race, and time within Surveillance, Epidemiology, and End Results registries, 2004 to 2021. Cancer Causes Control. 2025 Nov; 36(11):1589-1597.

View in: PubMed
Akinyemi O, Weldeslase T, Fasokun M, Eze O, Odusanya E, Yap A, Limage K, Hughes K, Cornwell E, Kalejaiye A. Medicaid expansion and thyroid cancer stage at presentation: A comparative study of two US states. Am J Surg. 2025 Sep; 247:116447.

View in: PubMed
Arshad S, Akinyemi OA, Fasokun M, Cornwell EE, Levy G. The Impact of the Affordable Care Act on Lung Cancer Stage at Presentation. Am Surg. 2025 Jul; 91(7):1086-1092.

View in: PubMed
Finati M, Cirulli GO, Chiarelli G, Stephens A, Tinsley S, Morrison C, Sood A, Buffi N, Lughezzani G, Salonia A, Briganti A, Montorsi F, Bettocchi C, Carrieri G, Rogers C, Abdollah F. The Role of Cytoreductive Nephrectomy in Contemporary Metastatic Renal Cell Carcinoma: An Other-Cause Mortality Match Population-Based Study. Clin Genitourin Cancer. 2025 Aug; 23(4):102374.

View in: PubMed

People

Explore

Similar Concepts

Top Journals